Effects of cholecalciferol supplementation and optimized calcium intakes on vitamin D status, muscle strength and bone health: A one-year pilot randomized controlled trial in adults with severe burns

Burns

Volumn 41, Issue 2, 2015, Pages 317-325

  Rousseau, Anne Franҫoise ^a   Foidart Desalle, Marguerite ^a   Ledoux, Didier ^a   Remy, Christophe ^a,b   Croisier, Jean Louis ^b   Damas, Pierre ^a   Cavalier, Etienne ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Bone mineral density; Burn injury; Isokinetic dynamometry; Muscle strength; Vitamin D

Indexed keywords

CALCIUM CARBONATE; COLECALCIFEROL; VITAMIN D; BONE DENSITY CONSERVATION AGENT; CALCIUM; VITAMIN;

ADULT; ADULT DISEASE; ARTICLE; BELGIAN; BODY MASS; BONE DENSITY; BONE METABOLISM; BONE REMODELING; BONE STRENGTH; BURN; BURN PATIENT; CALCIUM INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYNAMOMETRY; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; MALE; MEDICATION COMPLIANCE; MUSCLE STRENGTH; PHYSICAL ACTIVITY; QUADRICEPS FEMORIS MUSCLE; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION; BLOOD; COMPLICATION; DIET SUPPLEMENTATION; KNEE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; SKELETAL MUSCLE; VITAMIN D DEFICIENCY;

ADULT; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BURNS; CALCIUM; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; PILOT PROJECTS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84922840195     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2014.07.005     Document Type: Article

References (44)

1. Klein GL. Burn-induced bone loss: importance, mechanisms, and management. J Burns Wounds 2006;5:e5.
2. Klein GL, Herndon DN, Rutan TC, Sherrard DJ, Coburn JW, Langman CB, et al. Bone disease in burn patients. J Bone Miner Res 1993;8:337-45.
3. Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, Norbury WB, et al. Pathophysiologic response to severe burn injury. Ann Surg 2008;248:387-401.
4. Mason RS, Sequeira VB, Gordon-Thomson C, Vitamin D:. the light side of sunshine. Eur J Clin Nutr 2011;65: 986-93.
5. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30.
6. Rousseau AF, Ledoux D, Damas P, Cavalier E. Hypovitaminosis D and burn injury. Rev Med Liege 2013;68:574-8.
7. Klein GL, Chen TC, Holick MF, Langman CB, Price H, Celis MM, et al. Synthesis of vitamin D in skin after burns. Lancet 2004;363:291-2.
8. Cavalier E, Delanaye P, Chapelle JP, Souberbielle JC. Vitamin D: current status and perspectives. Clin Chem Lab Med 2009;47:120-7.
9. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
10. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 2013;12:976-89.
11. Schumann AD, Paxton RL, Solanki NS, Kurmis RJ, Mackie IP, Varey AH, et al. Vitamin D deficiency in burn patients. J Burn Care Res 2012;33:731-5.
12. Dolecek R, Tymonova J, Adamkova M, Kadlcik M, Pohlidal A, Zavodna R. Endocrine changes after burns: the bone involvement. Acta Chir Plast 2003;45:95-103.
13. Rousseau AF, Damas P, Ledoux D, Cavalier E. Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: an observational study in acute burn patients. Burns 2014;40:865-70.
14. Kottler ML. Is vitamin D a key factor in muscle health? Endocrinology 2013;154:3963-4.
15. Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 2011;22:859-71.
16. Fardellone P, Sebert JL, Bouraya M, Bonidan O, Leclercq G, Doutrellot C, et al. Evaluation of the calcium content of diet by frequential self-questionnaire. Rev Rhum Mal Osteoartic 1991;58:99-103.
17. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498-504.
18. Morovat A, Catchpole A, Meurisse A, Carlisi A, Bekaert AC, Rousselle O, et al. IDS iSYS automated intact procollagen-1- N-terminus pro-peptide assay: method evaluation and reference intervals in adults and children. Clin Chem Lab Med 2013;51:2009-18.
19. Boonen S, Kaufman JM, Reginster JY, Devogelaer JP. Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium. Osteoporos Int 2003;14:110-5.
20. Schousboe JT, Shepherd JA, Bilezikian JP, Baim S. Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. J Clin Densitometry 2013;16:455-66. the official journal of the International Society for Clinical Densitometry.
21. Brunel E, Schnitzler M, Foidart-Dessalle M, Souberbielle JC, Cavalier E. A double-blind, placebo controlled, randomized trial to assess the impact of a monthly administration of 50,000 IU of vitamin D3 for 6 months on serum levels of 25- hydroxyvitamin D in healthy young adults. Int J Endocrinol 2013;2013:652648.
22. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010;303:1815-22.
23. Rossini M, Gatti D, Viapiana O, Fracassi E, Idolazzi L, Zanoni S, et al. Short-term effects on bone turnover markers of a single high dose of oral vitamin D(3). J Clin Endocrinol Metab 2012;97:E622-6.
24. Cipriani C, Romagnoli E, Pepe J, Russo S, Carlucci L, Piemonte S, et al. Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis. J Clin Endocrinol Metab 2013;98:2709-15.
25. Spedding S, Vanlint S, Morris H, Scragg R. Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? Nutrients 2013;5:5127-39.
26. Nishiyama KK, Boyd SK. In vivo assessment of trabecular and cortical bone microstructure. Clinical Calcium 2011;21:1011-9.
27. Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 2014;383:146-55.
28. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 2008;29:407-14.
29. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Clinical review: critical illness polyneuropathy and myopathy. Crit Care 2008;12:238.
30. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999-2006.
31. Leblanc AD, Schneider VS, Evans HJ, Engelbretson DA, Krebs JM. Bone mineral loss and recovery after 17 weeks of bed rest. J Bone Miner Res 1990;5:843-50.
32. Hughes MA, Myers BS, Schenkman ML. The role of strength in rising from a chair in the functionally impaired elderly. J Biomech 1996;29:1509-13.
33. Spyropoulos G, Tsatalas T, Tsaopoulos DE, Sideris V, Giakas G. Biomechanics of sit-to-stand transition after muscle damage. Gait Posture 2013;38:62-7.
34. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007;92:1415-23.
35. Reginster JY. Calcium and vitamin D for osteoporotic fracture risk. Lancet 2007;370:632-4.
36. Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011;26:455-7.
37. Suman OE, Spies RJ, Celis MM, Mlcak RP, Herndon DN. Effects of a 12-wk resistance exercise program on skeletal muscle strength in children with burn injuries. J Appl Physiol (1985) 2001;91:1168-75.
38. Neugebauer CT, Serghiou M, Herndon DN, Suman OE. Effects of a 12-week rehabilitation program with music & exercise groups on range of motion in young children with severe burns. J Burn Care Res 2008;29:939-48.
39. Demling RH, DeSanti L. Oxandrolone induced lean mass gain during recovery from severe burns is maintained after discontinuation of the anabolic steroid. Burns 2003;29:793-7.
40. Hart DW, Wolf SE, Ramzy PI, Chinkes DL, Beauford RB, Ferrando AA, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg 2001;233:556-64.
41. Przkora R, Herndon DN, Sherrard DJ, Chinkes DL, Klein GL. Pamidronate preserves bone mass for at least 2 years following acute administration for pediatric burn injury. Bone 2007;41:297-302.
42. Klein GL, Wimalawansa SJ, Kulkarni G, Sherrard DJ, Sanford AP, Herndon DN. The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study. Osteoporos Int 2005;16:631-5.
43. Borsheim E, Herndon DN, Hawkins HK, Suman OE, Cotter M, Klein GL. Pamidronate attenuates muscle loss following pediatric burn injury. J Bone Miner Res 2013.
44. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991-2000.